• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Point-Of-Care Diagnostic Market by Products, End Users, Over the Counter & Prescription Based - Global Forecast to 2018 - Product Image Special Offer Sale Banner

Point-Of-Care Diagnostic Market by Products, End Users, Over the Counter & Prescription Based - Global Forecast to 2018

  • ID: 2783460
  • March 2014
  • Region: Global
  • 452 Pages
  • Markets and Markets
Special Offer Banner
10%
OFF
Offer ends 31st Dec 2014
The global point-of-care diagnostics market is expected to reach $27.5 billion by 2018, at a CAGR of 9.3% from 2013 to 2018.

FEATURED COMPANIES

  • Abaxis, Inc.
  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • Bayer Healthcare Ag
  • Beckman Coulter, Inc.
  • Johnson & Johnson
  • MORE

Point-Of-Care Diagnostics / Testing Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018

The global POC diagnostics market is estimated to grow at a lower CAGR in developed countries; however, it is expected to witness high growth in emerging countries such as China, India, and Brazil. Factors such as rising prevalence of lifestyle and infectious diseases, increasing usage of home-based POC devices, technological advancements, and decreasing number of technicians in the central labs are propelling the growth of the POC diagnostics market. However, factors such as lack of alignment with definitive central lab methods, reluctance to change existing treatment practices and the recall of leading glucose monitoring devices are restraining the growth of this market.

In this report, the global POC diagnostics market has been segmented on the basis of category (infectious diseases testing kits, glucose monitoring kits, cardiac markers, pregnancy and fertility testing kits, and others) and end users (patient READ MORE >

Note: Product cover images may vary from those shown
The global point-of-care diagnostics market is expected to reach $27.5 billion by 2018, at a CAGR of 9.3% from 2013 to 2018.

FEATURED COMPANIES

  • Abaxis, Inc.
  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • Bayer Healthcare Ag
  • Beckman Coulter, Inc.
  • Johnson & Johnson
  • MORE

1 Introduction
1.1 Objectives Of The Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope

2 Research Methodology
2.1 Description Of The Point-Of-Care Diagnostics Demand Model
2.1.1 Increase In Disease Burden
2.1.2 Growth In Healthcare Expenditure
2.1.3 Progression Towards Healthcare Decentralization
2.1.4 Increasing Penetration Of Healthcare Insurance
2.2 Market Size Estimation
2.3 Market Crackdown & Data Triangulation
2.4 Market Share Estimation
2.4.1 Key Data Points Taken From Secondary Sources
2.4.2 Key Data Points From Primary Sources
2.4.3 Key Industry Insights
2.4.4 Assumptions

3 Executive Summary

4 Premium Insights
4.1 Attractive Market Opportunities In Point-Of-Care Diagnostics
4.2 Point-Of-Care Diagnostics Market In Asia-Pacific Region
4.3 Point-Of-Care Diagnostics Market: Developed Vs. Developing Nations
4.4 Global Point-Of-Care Diagnostics Market, By Products (2013-2018)
4.5 Product Growth Matrix
4.6 Life Cycle Analysis, By Geography
4.7 Market Chasm Analysis

5 Market Overview
5.1 Introduction
5.2 Evolution
5.3 Market Segmentation
5.3.1 POC Diagnostics Market By Product
5.3.2 Point-Of-Care Diagnostics Market By Prescription Mode
5.3.3 Market By End User
5.4 Market Dynamics
5.4.1 Drivers
5.4.1.1 High Prevalence Of Infectious Diseases In Developing Countries
5.4.1.2 Increasing Incidence Of Lifestyle Diseases (Cardiac Diseases And Diabetes)
5.4.1.3 Rising Usage Of Home-Based POC Devices Is Improving Patient Compliance
5.4.1.4 Private Investments And Venture Funding To Support Development Of New Products
5.4.1.5 Growing Government Support To Increase The Adoption Of POC Devices
5.4.1.6 Developments For New Therapeutic Areas To Mark Significant Progress In The Coming Years
5.4.1.7 Industry Has Been Witnessing Significant Technological Advancements Over The Last Five Years
5.4.1.8 Fostering Approval Of Novel Immunoassay Techniques
5.4.1.9 Large Number Of Awareness Campaigns/ Conferences In Developing Countries
5.4.1.10 Decreasing Number Of Skilled Technicians In Centralized System Is Increasing The Preference For POC Testing
5.4.2 Restraints
5.4.2.1 Lack Of Alignment With Definitive Central Lab Methods
5.4.2.2 Disadvantages Of POC Testing Over Central Lab Methods – A Setback For The Market Growth
5.4.2.3 Product Recalls To Stem The Growth Of Glucose Monitoring Devices Market
5.4.2.4 Reluctance Towards Changing The Existing Treatment Practices To Hinder The Market Growth
5.4.3 Opportunities
5.4.3.1 Emerging Markets (India, China, And Brazil) To Pave New Growth Avenues
5.4.3.2 Healthcare Decentralization - Converting Lab Tests To POC Tests
5.4.3.3 Miniaturization Of POC Testing Devices – Increasing Efficiency While Reducing Costs
5.4.4 Challenges
5.4.4.1 Pricing Pressures Owing To Reimbursement Cuts And Budget Constraints Hampering Profits
5.4.4.2 Stringent And Time-Consuming Regulatory Policies Are Significantly Increasing The Gestation Period For Product Launches
5.4.5 Burning Issues
5.4.5.1 Unfavorable Reimbursement Scenario Limiting The Acceptance Of POC Tests
5.4.5.2 In Spite The Advantages Of POC, High Cost Of Devices Is One Of The Prime Concerns
5.4.6 Winning Imperatives
5.4.6.1 Strategy Of Geographic Expansion In Emerging Markets
5.4.6.2 Strategy Of Development Of Low-Cost POC Devices
5.4.6.3 Strategy Of Development Of Multi-Assay POC Devices

6 Industry Trends
6.1 Introduction
6.2 Value Chain Analysis
6.3 Supply Chain Analysis
6.3.1 Key Influencers
6.4 Industry Trends
6.4.1 Standardization Of POC Testing Devices
6.4.2 Acquisition Of Small Players
6.4.3 Growing Focus On Microfluidics-Based POC Devices
6.4.3.1 Microfluidic Technology Based Lab-On-A-Chip Devices Will Bring Laboratory Testing To Patient’s Finger Tips
6.5 Pricing And Cost Analysis
6.6 Porter’s Five Forces Analysis
6.6.1 Threat From New Entrants
6.6.2 Threat From Substitutes
6.6.3 Bargaining Power Of Suppliers
6.6.4 Bargaining Power Of Buyers
6.6.5 Intensity Of Competitive Rivalry
6.7 Pest Analysis
6.7.1 Political Factors
6.7.2 Economic Factors
6.7.3 Social Factors
6.7.4 Technological Factors
6.8 Strategic Benchmarking
6.8.1 Technology Integration & Product Enhancement
6.8.2 Entry Into Tumor/Cancer Testing Market

7 Point-Of-Care Diagnostics Market, By Product
7.1 Introduction
7.2 Glucose Monitoring Kits Market
7.2.1 Glucose Monitoring Strips Market
7.2.2 Glucose Monitoring Devices Market
7.2.3 Lancets Market
7.3 Cardiac Markers Market
7.4 Infectious Diseases Testing Kits Market
7.4.1 Influenza Testing Kits Market
7.4.2 Hiv Testing Kits Market
7.4.3 Hepatitis Testing Kits Market
7.4.4 Sexually-Transmitted Diseases (Stds) Testing Kits Market
7.4.5 Tuberculosis (Tb) Testing Kits Market
7.4.6 Tropical Diseases Testing Kits Market
7.5 Coagulation Monitoring Kits Market
7.5.1 Prothrombin Time (Pt/Inr) Testing Kits Market
7.5.2 Activated Clotting Time (Act/Aptt) Testing Kits Market
7.6 Pregnancy And Fertility Testing Kits Market
7.6.1 Pregnancy Testing Kits Market
7.6.2 Fertility Testing Kits Market
7.7 Blood Gas/Electrolytes Testing Kits Market
7.8 Tumor/Cancer Markers Market
7.9 Urinalysis Testing Kits Market
7.10 Cholesterol Test Strips Market
7.11 Hematology Testing Kits Market
7.11.1 Hemoglobin Assay Kits Market
7.11.2 Hemostasis Assay Kits Market
7.12 Food Pathogens Testing Kits Market
7.13 Drugs Of Abuse Testing Kits Market
7.14 Fecal Occult Testing Kits Market
7.15 Other Testing Kits Market

8 Point-Of-Care Diagnostics Market, By Prescription Mode 133
8.1 Introduction
8.2 Prescription-Based Testing Kits Market
8.3 OTC Testing Kits Market

9 Point-Of-Care Diagnostics Market, By End User
9.1 Introduction
9.2 Patient Professional Monitoring Kits Market
9.2.1 Inpatient Monitoring Kits Market
9.2.2 Outpatient Monitoring Kits Market
9.2.3 Special Areas Monitoring Kits Market
9.2.4 Other Areas Professional Monitoring Kits Market
9.3 Patient Self-Monitoring Kits Market

10 Point-Of-Care Diagnostics Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest Of Europe (Roe)
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest Of Asia-Pacific
10.5 Rest Of The World (Row)
10.5.1 Latin America
10.5.2 Africa
10.5.3 Middle East

11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis, Point-Of-Care Diagnostics Market (Excluding Blood Glucose Monitoring Kits)
11.3 Market Share Analysis, Blood Glucose Monitoring Kits Market
11.4 Competitive Situation And Trends
11.4.1 New Product Launches
11.4.2 Agreements, Partnerships, Collaborations, & Joint Ventures
11.4.3 Mergers And Acquisitions
11.4.4 Expansions
11.4.5 Other Developments

12 Company Profiles
(Overview, Financials, Products & Services, Strategy, & Developments)*
12.1 Introduction
12.2 Abaxis, Inc.
12.3 Abbott Laboratories, Inc.
12.4 Alere, Inc.
12.5 Bayer Healthcare Ag (A Subsidiary Of Bayer Ag)
12.6 Beckman Coulter, Inc. (A Subsidiary Of Danaher Corporation)
12.7 Becton, Dickinson And Company
12.8 Johnson & Johnson
12.9 Nipro Diagnostics, Inc. (A Subsidiary Of Nipro Corporation)
12.10 Roche Diagnostics Limited (A Subsidairy Of F. Hoffmann-La Roche Ltd)
12.11 Siemens Healthcare (A Division Of Siemens Ag)
*Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.

13 Appendix
13.1 Insights Of Industry Experts
13.2 Introducing Rt: Real Time Market Intelligence
13.3 Available Customizations
13.4 Related Reports

List of Tables (191 Tables)

Table 1 Increasing Incidence Of Lifestyle Diseases Is Propelling The Growth Of Point-Of-Care Diagnostics Market
Table 2 Reluctance For Changes In Existing Treatment Procedure Is Restraining Market Growth
Table 3 Emerging Markets Are Paving New Growth Avenues For Players In POC Market
Table 4 Reduced Reimbursement And Budget Provisions Is Constraining Growth Of POC Market
Table 5 Global Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 6 Global Glucose Monitoring Kits Market, By Type, 2011–2018 ($Million)
Table 7 Glucose Monitoring Kits Market, By Geography, 2011–2018 ($Million)
Table 8 Glucose Monitoring Strips Market, By Geography, 2011–2018 ($Million) 95
Table 9 Glucose Monitoring Devices Market, By Geography, 2011–2018 ($Million) 96
Table 10 Lancets Market, By Geography, 2011–2018 ($Million)
Table 11 Cardiac Markers Market, By Geography, 2011–2018 ($Million)
Table 12 Global Infectious Diseases Testing Kits Market, By Product, 2011–2018 ($Million) 102
Table 13 Infectious Diseases Testing Kits Market, By Geography, 2011–2018 ($Million) 103
Table 14 Influenza Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 15 Hiv Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 16 Hepatitis Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 17 Stds Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 18 Tb Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 19 Tropical Diseases Testing Kits Market, By Geography, 2011–2018 ($Million) 108
Table 20 Global Coagulation Monitoring Kits Market, By Type, 2011–2018 ($Million) 110
Table 21 Coagulation Monitoring Kits Market, By Geography, 2011–2018 ($Million) 111
Table 22 Prothrombin Time (Pt/Inr) Testing Kits Market, By Geography, 2011–2018 ($Million) 112
Table 23 Activated Clotting Time (Act/Aptt) Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 24 Global Pregnancy And Fertility Testing Kits Market, By Type, 2011–2018 ($Million) 115
Table 25 Pregnancy And Fertility Testing Kits Market, By Geography, 2011–2018 ($Million) 116
Table 26 Pregnancy Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 27 Fertility Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 28 Blood Gas/Electrolytes Testing Kits Market, By Geography, 2011–2018 ($Million) 118
Table 29 Tumor/Cancer Markers Market, By Geography, 2011–2018 ($Million)
Table 30 Urinalysis Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 31 Cholesterol Test Strips Market, By Geography, 2011–2018 ($Million)
Table 32 Global Hematology Testing Kits Market, By Type, 2011–2018 ($Million)
Table 33 Hematology Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 34 Hemoglobin Assay Kits Market, By Geography, 2011–2018 ($Million)
Table 35 Hemostasis Assay Kits Market, By Geography, 2011–2018 ($Million)
Table 36 Food Pathogens Testing Kits Market, By Geography, 2011–2018 ($Million) 128
Table 37 Drugs Of Abuse Testing Kits Market, By Geography, 2011–2018 ($Million) 129
Table 38 Fecal Occult Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 39 Other Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 40 Global POC Diagnostics Market, By Prescription Mode, 2011–2018 ($Million) 135
Table 41 Prescription-Based Testing Kits Market, By Geography, 2011–2018 ($Million) 136
Table 42 OTC Testing Kits Market, By Geography, 2011–2018 ($Million)
Table 43 Global POC Diagnostics Market, By End User, 2011–2018 ($Million)
Table 44 Patient Professional Monitoring Kits Market, By Type, 2011–2018 ($Million) 144
Table 45 Inpatient Monitoring Kits Market, By Geography, 2011–2018 ($Million)
Table 46 Outpatient Monitoring Kits Market, By Geography, 2011–2018 ($Million) 146
Table 47 Pecial Areas Monitoring Kits Market, By Geography, 2011–2018 ($Million) 147
Table 48 Other Areas Professional Monitoring Kits Market, By Geography, 2011–2018 ($Million)
Table 49 Patient Self-Monitoring Kits Market, By Geography, 2011–2018 ($Million) 148
Table 50 Point-Of-Care Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 51 North America: POC Diagnostics Market, By Country, 2011–2018 ($Million) 154
Table 52 North America: POC Diagnostics Market, By Product, 2011–2018 ($Million) 155
Table 53 North America: Glucose Monitoring Kits Market,By Country, 2011–2018 ($Million) 155
Table 54 North America: Cardiac Markers Market, By Country, 2011–2018 ($Million) 156
Table 55 North America: Infectious Diseases Testing Kits Market, By Country, 2011–2018 ($Million)
Table 56 North America: Coagulation Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 57 North America: Pregnancy And Fertility Testing Kits Market, By Country, 2011–2018 ($Million) 157
Table 58 North America: Blood Gas And Electrolytes Testing Kits Market, By Country, 2011–2018 ($Million) 158
Table 59 North America: Tumor/Cancer Markers Market, By Country, 2011–2018 ($Million) 158
Table 60 North America: Urinalysis Testing Kits Market, By Country, 2011–2018 ($Million) 159
Table 61 North America: Cholestrol Test Strips Market, By Country, 2011–2018 ($Million) 159
Table 62 North America: Hematology Testing Kits Market, By Country, 2011–2018 ($Million) 160
Table 63 North America: Food Pathogens Testing Kits Market, By Country, 2011–2018 ($Million) 160
Table 64 North America: Drugs Of Abuse Testing Kits Market, By Country, 2011–2018 ($Million) 161
Table 65 North America: Fecal Occult Testing Kits Market, By Country, 2011–2018 ($Million) 161
Table 66 North America: Other Testing Kits Market, By Country, 2011–2018 ($Million) 162
Table 67 North America: Point-Of-Care Diagnostics Market, By Prescription Mode, 2011–2018 ($Million) 162
Table 68 North America: OTC Testing Kits Market, By Country, 2011–2018 ($Million) 163
Table 69 North America: Prescription-Based Testing Kits Market, By Country, 2011–2018 ($Million)
Table 70 North America: POC Diagnostics Market, By End-User, 2011–2018 ($Million) 164
Table 71 North America: Patient Self–Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 72 North America: Professional Monitoring Kits Market, By Country, 2011–2018 ($Million)
Table 73 U.S: POC Diagnostics Market, By Product, 2011–2018 ($Million)
Table 74 U.S.: Market, By Prescription Mode, 2011–2018 ($Million) 167
Table 75 U.S.: Market, By End User,2011–2018 ($Million)
Table 76 Canada: POC Diagnostics Market, By Product, 2011–2018 ($Million)
Table 77 Canada: Market, By Prescription Mode, 2011–2018 ($Million) 169
Table 78 Canada: Market, By End User, 2011–2018 ($Million)
Table 79 Mexico: Market, By Product, 2011–2018 ($Million)
Table 80 Mexico: Market, By Prescription Mode, 2011–2018 ($Million) 173
Table 81 Mexico: Market, By End User, 2011–2018 ($Million)
Table 82 Europe: Market, By Country, 2011–2018 ($Million)
Table 83 Europe: Market,By Product, 2011–2018 ($Million)
Table 84 Europe: Glucose Monitoring Kits Market, By Country, 2011–2018 ($Million) 177
Table 85 Europe: Cardiac Markers Market,By Country, 2011–2018 ($Million)
Table 86 Europe: Infectious Diseases Testing Kits Market, By Country, 2011–2018 ($Million) 178
Table 87 Europe: Coagulation Monitoring Kits Market, By Country, 2011–2018 ($Million) 178
Table 88 Europe: Pregnancy And Fertility Testing Kits Market, By Country, 2011–2018 ($Million)
Table 89 Europe: Blood Gas And Electrolytes Testing Kits Market,By Country, 2011–2018 ($Million)
Table 90 Europe: Tumor/Cancer Markers Market,By Country, 2011–2018 ($Million) 180
Table 91 Europe: Urinalysis Testing Kits Market, By Country, 2011–2018 ($Million) 180
Table 92 Europe: Cholestrol Test Strips Market, By Country, 2011–2018 ($Million) 181
Table 93 Europe: Hematology Testing Kits Market,By Country, 2011–2018 ($Million) 181
Table 94 Europe: Food Pathogens Testing Kits Market, By Country, 2011–2018 ($Million) 182
Table 95 Europe: Drugs Of Abuse Testing Kits Market, By Country, 2011–2018 ($Million) 182
Table 96 Europe: Fecal Occult Testing Kits Market,By Country, 2011–2018 ($Million) 183
Table 97 Europe: Other Testing Kits Market, By Country, 2011–2018 ($Million)
Table 98 Europe: POC Diagnostics Market, By Prescription Mode, 2011–2018 ($Million) 184
Table 99 Europe: OTC Testing Kits Market, By Country, 2011–2018 ($Million)
Table 100 Europe: Prescription-Based Testing Kits Market,By Country, 2011–2018 ($Million) 185
Table 101 Europe: Point-Of-Care Diagnostics Market, By End User, 2011–2018 ($Million)
Table 102 Europe: Patient Self-Monitoring Kits Market, By Country, 2011–2018 ($Million) 186
Table 103 Europe: Professional Monitoring Kits Market, By Country, 2011–2018 ($Million) 186
Table 104 Germany: POC Diagnostics Market, By Product, 2011–2018 ($Million)
Table 105 Germany: Market, By Prescription Mode, 2011–2018 ($Million) 188
Table 106 Germany: Market, By End User, 2011–2018 ($Million)
Table 107 France: POC Diagnostics Market, By Product, 2011–2018 ($Million)
Table 108 France: Market, By Prescription Mode, 2011–2018 ($Million) 190
Table 109 France: Market, By End User, 2011–2018 ($Million)
Table 110 U.K.: POC Diagnostics Market, By Product, 2011–2018 ($Million)
Table 111 U.K.: Market, By Prescription Mode, 2011–2018 ($Million) 192
Table 112 U.K.: Market, By End User, 2011–2018 ($Million)
Table 113 Italy: POC Diagnostics Market, By Product, 2011–2018 ($Million)
Table 114 Italy: Market, By Prescription Mode, 2011–2018 ($Million) 194
Table 115 Italy: Market, By End User, 2011–2018 ($Million)
Table 116 Spain: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 117 Spain: POC Diagnostics Market, By Prescription Mode, 2011–2018 ($Million) 196
Table 118 Spain: POC Diagnostics Market, By End User, 2011–2018 ($Million)
Table 119 Roe: POC Diagnostics Market,By Product, 2011–2018 ($Million)
Table 120 Roe: Market, By Prescription Mode, 2011–2018 ($Million) 198
Table 121 Roe: Market,By End User, 2011–2018 ($Million)
Table 122 Asia-Pacific: Point-Of-Care Diagnostics Market, By Country, 2011–2018 ($Million)
Table 123 Asia-Pacific: POC Diagnostics Market, By Product, 2011–2018 ($Million)
Table 124 Asia-Pacific: Glucose Monitoring Kits Market, By Country, 2011–2018 ($Million) 202
Table 125 Asia-Pacific: Cardiac Markers Market, By Country, 2011–2018 ($Million)
Table 126 Asia-Pacific: Infectious Diseases Testing Kits Market, By Country, 2011–2018 ($Million) 203
Table 127 Asia-Pacific: Coagulation Monitoring Kits Market, By Country, 2011–2018 ($Million) 203
Table 128 Asia-Pacific: Pregnancy And Fertility Testing Kits Market, By Country, 2011–2018 ($Million)
Table 129 Asia-Pacific: Blood Gas And Electrolytes Testing Kits Market, By Country, 2011–2018 ($Million) 204
Table 130 Asia-Pacific: Tumor/Cancer Markers Market, By Country, 2011–2018 ($Million) 205
Table 131 Asia-Pacific: Urinalysis Testing Kits Market, By Country, 2011–2018 ($Million) 205
Table 132 Asia-Pacific: Cholestrol Test Strips Market, By Country, 2011–2018 ($Million) 206
Table 133 Asia-Pacific: Hematology Testing Kits Market, By Country, 2011–2018 ($Million) 206
Table 134 Asia-Pacific: Food Pathogens Testing Kits Market, By Country, 2011–2018 ($Million) 207
Table 135 Asia-Pacific: Drugs Of Abuse Testing Kits Market, By Country, 2011–2018 ($Million) 207
Table 136 Asia-Pacific: Fecal Occult Testing Kits Market, By Country, 2011–2018 ($Million) 208
Table 137 Asia-Pacific: Other Testing Kits Market, By Country, 2011–2018 ($Million) 208
Table 138 Asia-Pacific: Point-Of-Care Diagnostics Market, By Prescription Mode, 2011–2018 ($Million) 209
Table 139 Asia-Pacific : OTC Testing Kits Market, By Country, 2011–2018 ($Million)
Table 140 Asia-Pacific: Prescription-Based Testing Kits Market, By Country, 2011–2018 ($Million) 210
Table 141 Asia-Pacific: Point-Of-Care Diagnostics Market, By End User, 2011–2018 ($Million)
Table 142 Asia-Pacific: Patient Self-Monitoring Kits Market, By Country, 2011–2018 ($Million) 211
Table 143 Asia-Pacific: Professional Monitoring Kits Market, By Country, 2011–2018 ($Million) 211
Table 144 Japan: POC Diagnostics Market, By Product, 2011–2018 ($Million)
Table 145 Japan: Market, By Prescription Mode, 2011–2018 ($Million) 213
Table 146 Japan: Market, By End User, 2011–2018 ($Million)
Table 147 China: POC Diagnostics Market, By Product, 2011–2018 ($Million)
Table 148 China: Market, By Prescription Mode, 2011–2018 ($Million) 216
Table 149 China: Market, By End User, 2011–2018 ($Million)
Table 150 India: Market, By Product, 2011–2018 ($Million)
Table 151 India: Market, By Prescription Mode, 2011–2018 ($Million) 219
Table 152 India: Market, By End User, 2011–2018 ($Million)
Table 153 Roa: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 154 Roa: POC Diagnostics Market, By Prescription Mode, 2011–2018 ($Million) 221
Table 155 Roa: POC Diagnostics Market, By End User, 2011–2018 ($Million)
Table 156 Row: POC Diagnostics Market, By Region, 2011–2018 ($Million)
Table 157 Row: POC Diagnostics Market, By Product, 2011–2018 ($Million)
Table 158 Row: Glucose Monitoring Kits Market, By Regions, 2011–2018 ($Million) 224
Table 159 Row: Cardiac Markers Market, By Regions, 2011–2018 ($Million)
Table 160 Row: Infectious Diseases Testing Kits Market, By Regions, 2011–2018 ($Million) 225
Table 161 Row: Coagulation Monitoring Kits Market, By Regions, 2011–2018 ($Million) 226
Table 162 Row: Pregnancy And Fertility Kits Market, By Regions, 2011–2018 ($Million) 226
Table 163 Row: Blood Gas And Electrolytes Testing Kits Market, By Regions, 2011–2018 ($Million)
Table 164 Row: Tumor/Cancer Markers Market, By Regions, 2011–2018 ($Million)
Table 165 Row: Urinalysis Testing Kits Market, By Regions, 2011–2018 ($Million)
Table 166 Row: Cholestrol Test Strips Market, By Regions, 2011–2018 ($Million)
Table 167 Row: Hematology Testing Kits Market, By Regions, 2011–2018 ($Million) 228
Table 168 Row: Food Pathogens Testing Kits Market, By Regions, 2011–2018 ($Million) 228
Table 169 Row: Drugs Of Abuse Testing Kits Market, By Regions, 2011–2018 ($Million) 229
Table 170 Row: Fecal Occult Testing Kits Market, By Regions, 2011–2018 ($Million) 229
Table 171 Row: Other Testing Kits Market, By Regions, 2011–2018 ($Million)
Table 172 Row: Point-Of-Care Diagnostics Market, By Prescription Mode, 2011–2018 ($Million) 230
Table 173 Row: OTC Testing Kits Market, By Regions, 2011–2018 ($Million)
Table 174 Row: Prescription-Based Testing Kits Market, By Regions, 2011–2018 ($Million) 231
Table 175 Row: Point-Of-Care Diagnostics Market, By End User, 2011–2018 ($Million)
Table 176 Row: Patient Self-Monitoring Kits Market, By Regions, 2011–2018 ($Million) 232
Table 177 Row: Professional Monitoring Kits Market, By Regions, 2011–2018 ($Million) 232
Table 178 Latin America: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million) 233
Table 179 Latin America: POC Diagnostics Market, By Prescription Mode, 2011–2018 ($Million) 234
Table 180 Latin America: POC Diagnostics Market, By End User, 2011–2018 ($Million) 234
Table 181 Africa: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 182 Africa: POC Diagnostics Market, By Prescription Mode, 2011–2018 ($Million) 236
Table 183 Africa: POC Diagnostics Market, By End User, 2011–2018 ($Million)
Table 184 Middle East: Point-Of-Care Diagnostics Market, By Product, 2011–2018 ($Million)
Table 185 Middle East: POC Diagnostics Market, By Prescription Mode, 2011–2018 ($Million)
Table 186 Middle East: POC Diagnostics Market, By End User, 2011–2018 ($Million) 238
Table 187 New Product Launches, 2011–2014
Table 188 Agreements, Partnerships, Collaborations, And Joint Ventures, 2011–2014 249
Table 189 Mergers And Acquisitions, 2011–2014
Table 190 Expansions, 2011–2014
Table 191 Other Developments, 2011–2014

List of Figures (87 Figures)

Figure 1 Global Point-Of-Care Diagnostics Market: Research Methodology
Figure 2 Prevalence Rate (%) Of Diabetes And Influenza Across Various Regions, 2011
Figure 3 Prevalence Rate (%) Of Hepatitis, Cardiovascular Diseases, And Cancer Across Various Regions, 2011
Figure 4 Healthcare Expenditure Across Various Prominent Countries In The Point-Of-Care Diagnostics Market, 2011
Figure 5 Decentralization Across Prominent Countries In The Point-Of-Care Diagnostics Market, 2013
Figure 6 Healthcare Insurance Across Prominent Countries In The Point-Of-Care Diagnostics Market, 2011
Figure 7 Market Size Estimation Methodology: Bottom-Up Approach
Figure 8 Market Size Estimation Methodology: Top-Down Approach
Figure 9 Break Down Of Primary Interviews: By Company Type, Designation, & Region
Figure 10 Point-Of-Care Diagnostics Products Market Snapshot (2013 Vs 2018): Market For Cardiac Markers Is Expected To Double In The Next Five Years
Figure 11 Global Point-Of-Care Diagnostics Market, By Product, 2013
Figure 12 Global Point-Of-Care Diagnostics Market Share, 2013
Figure 13 Attractive Market Opportunities In Point-Of-Care Diagnostics
Figure 14 Glucose Monitoring Kits Capture The Lion’s Share In The Emerging Asia-Pacific Market
Figure 15 Developing Markets To Grow Two Times Faster Than The Developed Ones
Figure 16 3/4th Of The Total Market Growth Will Come From Top Four Product Segments In 2013 - 2018
Figure 17 Cancer Biomarkers Unravel New Revenue POCkets For Market Players
Figure 18 Latin American Market Soon To Enter Exponential Growth Phase In Coming Years
Figure 19 Reluctance Among Patients To Change Existing Healthcare Practices Is A Major Obstacle
Figure 20 Information Technology To Play A Crucial Role In POC Industry
Figure 21 Point-Of-Care Diagnostics Market Segmentation: By Product
Figure 22 Point-Of-Care Diagnostics Market Segmentation: By Prescription Mode
Figure 23 Point-Of-Care Diagnostics Market Segmentation: By End User
Figure 24 Increasing Prevalence Of Lifestyle Diseases Will Spur The Demand For POC Testing
Figure 25 Value Chain Analysis (2013): Major Value Is Added During Manufacturing And Assembly Phase
Figure 26 Supply Chain: Direct Distribution Is The Most Preferred Strategy Followed By Prominant Players
Figure 27 Standardization Of POC Devices Is The Leading Trend Among The Key Market Players
Figure 28 Pricing Trend (2013-2018): Two Fold Decline Is Expected In Price Of POC Devices In Apac Compared To North America
Figure 29 Porter’s Five Forces Analysis (2013): Low Capital Requirement Is Increasing Competition In The Industry
Figure 30 Point-Of-Care Diagnostics Market: Pest Analysis, 2013
Figure 31 Strategic Benchmarking: Roche And Bd Diagnostics Largely Adopted Inorganic Growth Strategies For Technology Integration And Product Enhancement
Figure 32 Strategic Benchmarking: Spotlight Falls On Roche In Tumor/Cancer Testing Market With Its Big Strategic Moves
Figure 33 More Than Half Of The Market Is Dominated By Glucose Monitoring Kits
Figure 34 Strips Will Continue To Control The Glucose Monitoring Kits Market With More Than 3/4th Of The Share In 2018
Figure 35 Innovations In Self-Monitoring Glucose Meters To Push The Growth Of Glucose Monitoring Devices Market
Figure 36 High Prevalence Of Diabetes In Apac Region Is Fueling The Growth Of Glucose Monitoring Kits Market
Figure 37 Cardiac Markers In Apac Is Expected To Double By 2018 Due To The Increasing Burden Of Cvds
Figure 38 Hepatitis Testing Kits Market Size Is Poised To Increase Two Fold By 2018
Figure 39 Tropical Diseases Testing Kits Is The Fastest Growing Segment In The Infectious Diseases Testing Kits Market
Figure 40 Infectious Diseases Testing Kits Market To Witness Double-Digit Growth Across All Geographies From 2013 To 2018
Figure 41 Pt/Inr Testing Kits Dominate The Coagulation Kits Market, But Act/Aptt Testing Kits Will Make The Money Faster
Figure 42 Prothrombin Time Testing Kits To Clock $1 Million By 2018
Figure 43 Coagulation Testing Kits Market To See Highest Growth Rate In Apac
Figure 44 Pregnancy Testing Kits Market To Hit One Billion Mark, By 2018
Figure 45 Increasing Awareness About Family Planning Is Boosting The Apac Pregnancy Testing Kits Market
Figure 46 Huge Investments For Cancer Research Activities Is Driving The Tumor Markers Market
Figure 47 Increasing Prevalence Of Urinary Tract Infections Will Lead To The Growth Of Urinalysis Testing Kits Market
Figure 48 Hemoglobin Assay Kits Segment Will Continue To Lead The Hematology Kits Market
Figure 49 Hemoglobin Assay Kits Dominates The Hematology Testing Kits Market
Figure 50 Over-The-Counter (OTC) Testing Kits Unfolds New Avenues In The Point-Of-Care Diagnostics Market
Figure 51 Asia-Pacific Prescription-Based Testing Kits Makret To Grow At The Highest Cagr In The Forecast Period
Figure 52 North America Commanded The Major Share Of OTC Testing Kits Market In 2013
Figure 53 Broad End User Base Of Point-Of-Care Testing Kits
Figure 54 Patient Self-Monitoring Kits Market Set To Outpace Professional Monitoring Segment In Growth
Figure 55 Outpatient Monitoring Kits Would Drive The Growth Of Professional Monitoring Kits Market
Figure 56 Outpatient Monitoring Kits Is The Fastest Growing Segment In The Professional Monitoring Kits Market
Figure 57 Rising Prevalence Of Lifestyle Diseases Will Continue To Drive The Market
Figure 58 Geographic Snapshot (2013) – Rapid Growth Markets Are Emerging As New Hot Spots
Figure 59 North America Market Snapshot: Demand Will Be Driven By Alarming Prevalence Rate Of Lifestyle Diseases
Figure 60 High Burden Of Life Style Diseases Is Stimulating The Adoption Of POC Diagnosis In U.S.
Figure 61 Government Support To Develop The Point-Of-Care Diagnostics Market Is Boosting The Mexican Market Growth Figure 62 Germany Commands A Major Chunk Of The European Point-Of-Care Diagnostics Market In 2013
Figure 63 Asia-Pacific Point-Of-Care Diagnostics Market Snapshot – China Is The Most Lucrative Market
Figure 64 China To Grow Up The Ladder By Three Steps To Become The Second Largest Market By 2018 ($Million)
Figure 65 Poor Economic Condition Is Limiting The Growth, Government Initiatives - New Ray Of Hope
Figure 66 Companies Adopted Product Innovation As The Key Growth Strategy Over The Last Three Years
Figure 67 Global Point-Of-Care Diagnostics (Excluding Blood Glucose Monitoring Kits) Market Share, By Key Player, 2012 Figure 68 Battle For Market Share: New Product Launches Was The Key Strategy
Figure 69 Geographic Revenue Mix Of Top 5 Market Players
Figure 70 Competitive Benchmarking Of Key Market Players (2007-2013): Alereemerged As The Champion Owing To Its Diversified POC Product Portfolio
Figure 71 Abaxis, Inc.: Business Overview
Figure 72 Abbott Laboratories, Inc.: Business Overview
Figure 73 Abbott Laboratories, Inc.: Market Strategy,2011–2013
Figure 74 Alere, Inc.: Business Overview
Figure 75 Alere, Inc.: Market Strategy, 2011–2013
Figure 76 Bayer Healthcare Ag: Business Overview
Figure 77 Beckman Coulter, Inc.: Business Overview
Figure 78 Beckman Coulter, Inc.: Major Stratgy, 2011–2014
Figure 79 Becton, Dickinson And Company: Business Overview
Figure 80 Becton, Dickinson And Company: Market Strategy, 2011–2014
Figure 81 Johnson & Johnson: Business Overview
Figure 82 Johnson & Johnson: Market Strategy, 2011–2013
Figure 83 Nipro Diagnostics, Inc.: Business Overview
Figure 84 Roche Diagnostics Limited: Business Overview
Figure 85 Roche Diagnostics Limited: Market Strategy, 2011–2013
Figure 86 Siemens Healthcare: Business Overview
Figure 87 Siemens Healthcare: Market Strategy, 2011–2013

Note: Product cover images may vary from those shown
The global point-of-care diagnostics market is expected to reach $27.5 billion by 2018, at a CAGR of 9.3% from 2013 to 2018.

FEATURED COMPANIES

  • Abaxis, Inc.
  • Abbott Laboratories, Inc.
  • Alere, Inc.
  • Bayer Healthcare Ag
  • Beckman Coulter, Inc.
  • Johnson & Johnson
  • MORE

The global Point-Of-Care diagnostics market has been segmented into infectious diseases testing kits, glucose monitoring kits, coagulation monitoring kits, urinalysis testing kits, hematology testing kits, cholesterol test strips, drugs of abuse testing kits, cardiac markers, blood gas/electrolytes testing kits, tumor/cancer markers, pregnancy and fertility testing kits, fecal occult testing kits, food pathogens testing kits, and others. The glucose monitoring kits segment held the largest share of the market in 2013 and is poised to grow at a CAGR of 8.5% in the forecast period. Based on the end users, the global market is segmented into patient professional monitoring kits and patient self-monitoring kits. Furthermore, based on the prescription mode, the global market has been segmented into OTC and prescription-based Point-Of-Care diagnostics market.

The global point-of-care diagnostics market is expected to reach $27.5 billion by 2018, at a CAGR of 9.3% from 2013 to 2018. A number of factors such as the rising prevalence of lifestyle and infectious diseases, increasing usage of home-based POC devices, and decreasing number of technicians in central labs are driving the growth of the global market. Furthermore, growing government support and increasing private investments and venture funding to support new product development are other factors that are propelling the growth of the market. In addition, rising adoption of POC devices, expansion of therapeutic horizon, and technological advancements is further fueling the growth of this market.

However, a few pivotal factors such as lack of alignment with definitive central lab methods, and reluctance to change existing treatment practices are hindering the growth of this market. Moreover, disadvantages of point-of-care testing over central lab methods and recalls of leading glucose monitoring devices are the foremost challenges faced by industry players.

The global point-of-care diagnostics market is dominated by North America, followed by Europe, Asia-Pacific and the Rest of the World (RoW). North America will continue to dominate the market in the forecast period, followed by the Asia-Pacific. However, the Asia-Pacific region is expected to grow at the highest CAGR of ~13.6% from 2013 to 2018. Over the next five years, the growth of the market in the Asia-Pacific region is likely to be centered at Japan, China, and India. A number of factors such as the huge patient population base, increasing funding/investment toward the development of point of care diagnosticproducts, growing focus of both international and domestic players on the Asia-Pacific point-of-care diagnostics market, and large number of R&D activities are driving the growth of the market in the Asia-Pacific region.

New product launches is the key strategy followed by leading market players to ensure their growth in the Point-Of-Care Diagnostics / Testing market. Moreover, partnerships, agreements, collaboration, and joint ventures; mergers and acquisitions; and expansions are some other growth strategies adopted by industry players in the global market.

The point-of-care diagnostics market is a diversified and competitive market with a large number of players. The market is dominated by various players, depending on their core competencies. The key players in this market are Roche Diagnostics Ltd. (Switzerland), Abbott Laboratories (U.S.), Alere Inc. (U.S.), Siemens AG (Germany), and Beckman Coulter, Inc. (U.S.).

Note: Product cover images may vary from those shown
The global point-of-care diagnostics market is expected to reach $27.5 billion by 2018, at a CAGR of 9.3% from 2013 to 2018.

- Abaxis, Inc.
- Abbott Laboratories, Inc.
- Alere, Inc.
- Bayer Healthcare Ag
- Beckman Coulter, Inc.
- Becton, Dickinson And Company
- Johnson & Johnson
- Nipro Diagnostics, Inc.
- Roche Diagnostics Limited
- Siemens Healthcare

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos